FDA Inspection 1021337 — Rita M. Egan, M.D., Ph.D.

Rita M. Egan, M.D., Ph.D. — FEI 3013503592

The FDA completed an inspection of Rita M. Egan, M.D., Ph.D. on August 3, 2017 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 3, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lexington, KY (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent